Literature DB >> 3559859

The role of intraluminal tension and pH in the development of necrotizing enterocolitis: an animal model.

W I Garstin, B D Kenny, D McAneaney, C C Patterson, V E Boston.   

Abstract

Presented is an in vivo animal model of necrotizing enterocolitis (NEC) in which we used an isolated loop of rabbit colon. Changes in mucosal perfusion and macroscopic and microscopic appearances were studied after exposure of the mucosa to different intraluminal tensions and pHs. Mucosal perfusion was reduced with increasing intraluminal tension and decreasing pH. Histologic changes consistent with NEC were identified after five hours when the mucosa had been exposed to both increased intraluminal tension and decreased pH. Factors affecting intraluminal tension and pH could influence the development of NEC in the neonate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3559859     DOI: 10.1016/s0022-3468(87)80328-7

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Characterization of a necrotizing enterocolitis model in newborn mice.

Authors:  Runlan Tian; Shirley Xl Liu; Cara Williams; Thomas D Soltau; Reed Dimmitt; Xiaotian Zheng; Isabelle G De Plaen
Journal:  Int J Clin Exp Med       Date:  2010-09-21

Review 2.  Necrotising enterocolitis and localised intestinal perforation: different diseases or ends of a spectrum of pathology.

Authors:  V E Boston
Journal:  Pediatr Surg Int       Date:  2006-05-04       Impact factor: 1.827

Review 3.  Neonatal necrotising enterocolitis.

Authors:  M Rohatgi; S Chandna
Journal:  Indian J Pediatr       Date:  1988 Nov-Dec       Impact factor: 1.967

4.  Hemodynamic and permeability characteristics of acute experimental necrotizing enterocolitis.

Authors:  M J Miller; J Adams; X A Gu; X J Zhang; D A Clark
Journal:  Dig Dis Sci       Date:  1990-10       Impact factor: 3.199

Review 5.  Paneth cells and necrotizing enterocolitis.

Authors:  Mark A Underwood
Journal:  Gut Microbes       Date:  2012-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.